Loading...

Dermapharm Holding SE

DMPHF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$39.56
$0.00(0.00%)
U.S. Market opens in 14h 21m

Dermapharm Holding SE (DMPHF) Stock Overview

Explore Dermapharm Holding SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.1B
P/E Ratio13.62
EPS (TTM)$2.21
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$33.84
3 Months$36.36
1 Year Target$37.66

DMPHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dermapharm Holding SE (DMPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $37.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.62 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-7.31%
5-Year Change
-7.31%
All-Time (Max) Change
-7.31%

Contact Information

https://www.dermapharm.de
49 89 6 41 86 0
Lil-Dagover-Ring 7, Grünwald, NaN, 82031

Company Facts

3,610 Employees
IPO DateNov 29, 2022
CountryDE
Actively Trading

Frequently Asked Questions